Total Payments
$605,555
2024 Payments
$43,342
Companies
29
Transactions
850
Medicare Patients
979
Medicare Billing
$93,905

Payment Breakdown by Category

Other$451,697 (74.6%)
Travel$78,474 (13.0%)
Consulting$55,920 (9.2%)
Food & Beverage$19,423 (3.2%)
Education$40.22 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $451,697 209 74.6%
Travel and Lodging $78,474 265 13.0%
Consulting Fee $55,920 21 9.2%
Food and Beverage $19,423 353 3.2%
Education $40.22 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $139,658 138 $0 (2024)
Novartis Pharmaceuticals Corporation $116,584 160 $0 (2024)
PFIZER INC. $113,096 148 $0 (2023)
Merck Sharp & Dohme LLC $101,147 103 $0 (2024)
Lilly USA, LLC $61,405 97 $0 (2024)
CVRx, Inc. $56,737 81 $0 (2024)
Abbott Laboratories $4,989 39 $0 (2024)
Novo Nordisk Inc $3,995 2 $0 (2024)
Impulse Dynamics (USA) Inc. $2,289 3 $0 (2022)
Medtronic Vascular, Inc. $1,541 11 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $43,342 78 CVRx, Inc. ($38,755)
2023 $22,589 52 CVRx, Inc. ($17,903)
2022 $119,713 116 Merck Sharp & Dohme LLC ($79,590)
2021 $91,721 100 Boehringer Ingelheim Pharmaceuticals, Inc. ($54,845)
2020 $55,052 76 PFIZER INC. ($35,922)
2019 $153,375 222 PFIZER INC. ($64,474)
2018 $38,790 69 Novartis Pharmaceuticals Corporation ($28,763)
2017 $80,972 137 Novartis Pharmaceuticals Corporation ($75,660)

All Payment Transactions

850 individual payment records from CMS Open Payments — Page 1 of 34

Date Company Product Nature Form Amount Type
12/23/2024 CVRx, Inc. Barostim Neo System (Device) Consulting Fee Cash or cash equivalent $4,000.00 General
Category: Heart Failure and Hypertension
12/11/2024 CVRx, Inc. Barostim Neo System (Device) Consulting Fee Cash or cash equivalent $4,500.00 General
Category: Heart Failure and Hypertension
12/03/2024 CVRx, Inc. Barostim Neo System (Device) Travel and Lodging Cash or cash equivalent $745.95 General
Category: Heart Failure and Hypertension
11/20/2024 CVRx, Inc. Barostim Neo System (Device) Travel and Lodging Cash or cash equivalent $300.37 General
Category: Heart Failure and Hypertension
11/19/2024 CVRx, Inc. Barostim Neo System (Device) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: Heart Failure and Hypertension
11/13/2024 CVRx, Inc. Barostim Neo System (Device) Travel and Lodging Cash or cash equivalent $217.74 General
Category: Heart Failure and Hypertension
11/13/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $107.03 General
Category: Heart Failure and Hypertension
11/13/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $97.70 General
Category: Heart Failure and Hypertension
11/13/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $18.94 General
Category: Heart Failure and Hypertension
11/13/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $5.00 General
Category: Heart Failure and Hypertension
11/08/2024 CVRx, Inc. Barostim Neo System (Device) Travel and Lodging Cash or cash equivalent $665.98 General
Category: Heart Failure and Hypertension
11/01/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $29.62 General
Category: Heart Failure and Hypertension
10/24/2024 Abbott Laboratories THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) Food and Beverage In-kind items and services $23.30 General
Category: Heart Failure
10/18/2024 CVRx, Inc. Barostim Neo System (Device) Travel and Lodging Cash or cash equivalent $391.96 General
Category: Heart Failure and Hypertension
10/10/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.25 General
Category: Cardio-renal
10/09/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $97.59 General
Category: Heart Failure and Hypertension
10/09/2024 Abbott Laboratories THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) Food and Beverage In-kind items and services $52.79 General
Category: Heart Failure
10/01/2024 CVRx, Inc. Barostim Neo System (Device) Consulting Fee Cash or cash equivalent $4,000.00 General
Category: Heart Failure and Hypertension
10/01/2024 CVRx, Inc. Barostim Neo System (Device) Travel and Lodging Cash or cash equivalent $359.96 General
Category: Heart Failure and Hypertension
10/01/2024 CVRx, Inc. Barostim Neo System (Device) Travel and Lodging Cash or cash equivalent $34.00 General
Category: Heart Failure and Hypertension
09/25/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $153.60 General
Category: Heart Failure and Hypertension
09/23/2024 ABIOMED Impella (Device) Food and Beverage Cash or cash equivalent $148.13 General
Category: Cardiology/Vascular Diseases
09/19/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $20.09 General
Category: Cardiology/Vascular Diseases
09/16/2024 Abbott Laboratories THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) Food and Beverage In-kind items and services $13.41 General
Category: Heart Failure
08/29/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $19.40 General
Category: CARDIOVASCULAR

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 264 387 $109,138 $29,904
2022 10 346 528 $119,327 $34,794
2021 3 210 286 $43,455 $16,575
2020 5 159 227 $31,263 $12,632
Total Patients
979
Total Services
1,428
Medicare Billing
$93,905
Procedure Codes
24

All Medicare Procedures & Services

24 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 33 90 $24,091 $8,364 34.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 61 92 $21,916 $6,743 30.8%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Facility 2023 100 102 $25,935 $5,076 19.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 38 44 $14,755 $4,957 33.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 20 44 $8,192 $2,583 31.5%
99291 Critical care, first 30-74 minutes Facility 2023 12 15 $14,250 $2,182 15.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 53 123 $25,495 $9,930 39.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 65 116 $22,790 $9,015 39.6%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Facility 2022 131 136 $29,900 $7,005 23.4%
99291 Critical care, first 30-74 minutes Facility 2022 11 28 $22,729 $4,769 21.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 27 29 $3,108 $1,250 40.2%
93750 Evaluation of lower heart chamber assist device Facility 2022 14 40 $5,540 $1,248 22.5%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 11 11 $3,316 $1,175 35.4%
93308 Ultrasound of heart, follow-up Facility 2022 12 17 $4,051 $302.43 7.5%
93321 Ultrasound of heart blood flow, valves and chambers, follow-up Facility 2022 11 14 $2,170 $68.88 3.2%
93325 Ultrasound of heart with color-depicted blood flow, rate and valve function Facility 2022 11 14 $227.24 $30.18 13.3%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 69 127 $13,335 $6,370 47.8%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Facility 2021 104 104 $21,320 $5,708 26.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 37 55 $8,800 $4,497 51.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 39 66 $10,560 $5,571 52.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 62 89 $9,345 $3,241 34.7%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Facility 2020 29 30 $6,150 $1,766 28.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 17 21 $2,415 $1,245 51.6%
93750 Evaluation of lower heart chamber assist device with physician analysis Facility 2020 12 21 $2,793 $808.44 28.9%

About Amarinder Bindra

Amarinder Bindra is a Student in an Organized Health Care Education/Training Program healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1528218286.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amarinder Bindra has received a total of $605,555 in payments from pharmaceutical and medical device companies, with $43,342 received in 2024. These payments were reported across 850 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($451,697).

As a Medicare-enrolled provider, Bindra has provided services to 979 Medicare beneficiaries, totaling 1,428 services with total Medicare billing of $93,905. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.

Practice Information

Products in Payments

  • JARDIANCE (Drug) $199,474
  • VYNDAQEL (Drug) $109,760
  • VERQUVO (Drug) $101,147
  • ENTRESTO (Drug) $96,591
  • Barostim Neo System (Device) $56,737
  • Ozempic (Drug) $3,954
  • CardioMEMS HF System (Device) $2,018
  • Optimizer Smart System (Device) $2,000
  • Circulatory Support (Device) $1,343
  • HeartWare HVAD (Device) $1,208
  • TEGSEDI (Drug) $946.00
  • HeartMate 3 Left Ventricular Assist Device (Device) $461.95
  • Impella (Device) $411.22
  • THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $382.65
  • HeartMate (Device) $375.53
  • remede System (Device) $314.44
  • LifeVest (Device) $299.85
  • Optimizer (Device) $288.65
  • LEQVIO (Drug) $174.79
  • PRALUENT ALIROCUMAB INJECTION (Biological) $167.42

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Dallas